5-Amino-1-methylquinolin-1-ium iodide (5-Amino-1MQ) is a membrane-permeable small-molecule NNMT inhibitor (IC50 ~1.2 µM) investigated in cellular NAD+ salvage, SAM preservation, and adipocyte lipolysis models.
Scientific Profile & Research Key Points: 5-Amino-1MQ
5-Amino-1-methylquinolin-1-ium iodide (5-Amino-1MQ) is a membrane-permeable small-molecule NNMT inhibitor (IC50 ~1.2 µM) investigated in cellular NAD+ salvage, SAM preservation, and adipocyte lipolysis models.
Active Batch Release Specifications (Lot SL-2026-101)
Analytical release verification for current 5-Amino-1MQ (10 mg) inventory
| Batch Lot # | Release Date | Analytical Method | Purity Spec | Endotoxin (LAL) | Moisture |
|---|---|---|---|---|---|
| SL-2026-101 | 2026-10-28 | HPLC-UV + LC-MS (Small-Molecule Verification) | ≥99.0% (Chromatographic Peak) | <0.5 EU/mg | <2.8% (Karl Fischer) |
Laboratory Solubilization & Storage Protocol
Recommended Solvent / Handling
Sterile DMSO (>25 mg/mL) or sterile aqueous buffer (~5 mg/mL)
Temperature & Stability
Store crystalline solid at -20°C shielded from light. DMSO stock aliquots remain stable at -80°C for up to 6 months.
5-Amino-1MQ — Technical Questions & Answers
What is the molar concentration when reconstituting 5-Amino-1MQ (10 mg) in 2.0 mL?
Reconstituting the full 10 mg vial of 5-Amino-1MQ (MW 286.11 g/mol) in 2.0 mL of diluent produces a 5.00 mg/mL stock solution — equivalent to approximately 17.48 mM (17,476 µM) gross molarity before Net Peptide Content (NPC) adjustment.
How does 5-Amino-1MQ's salt form affect assay mass calculations?
5-Amino-1MQ (CAS 42464-96-0, formula C10H11IN2) is supplied as Iodide (I⁻) salt (~44.3% counterion mass). Because counterions and residual bound water contribute to gross lyophilized weight, quantitative receptor-binding assays should apply batch Net Peptide Content (NPC) or active-ion correction rather than gross cake weight alone.
Which analytical methods verify 5-Amino-1MQ Lot SL-2026-101 and what pathway does it target?
Lot SL-2026-101 undergoes HPLC-UV + LC-MS (Small-Molecule Verification) confirming ≥99.0% (Chromatographic Peak) and identity against 286.11 g/mol. In preclinical literature, 5-Amino-1MQ targets Nicotinamide N-methyltransferase (NNMT) (Neelakantan H. et al., Biochem Pharmacol (2018) — Selective NNMT inhibition in adipocyte energy metabolism (PMID: 29258821)).
Related Scientific Monographs
Peer-reviewed mechanism summaries and analytical protocols
SLU-PP-332: Synthetic Pan-ERR Agonist Chemistry, DMSO Solubility & Mitochondrial Biogenesis
Analytical profile of small-molecule pan-ERR agonist SLU-PP-332 (CAS 303760-60-3): nuclear receptor EC50 selectivity, mitochondrial respiration models, and DMSO stock preparation.
Cagrilintide vs Retatrutide: Amylin/Calcitonin Receptors vs Triple Incretin Agonism
Biochemical comparison of long-acting amylin analogue Cagrilintide (AM833) against triple incretin agonist Retatrutide and dual-pathway Cagrilintide + Semaglutide combinations.
Survodutide vs Mazdutide vs Retatrutide: Dual GLP-1/Glucagon and Triple Agonist Biochemistry
Comparative receptor pharmacology of Survodutide (BI 456906), Mazdutide (IBI362), and Retatrutide (LY3437943): GLP-1R/GCGR/GIPR potency ratios and stability.
Related Metabolic & Incretin Research Compounds
View category →